- Home
- BCAB
BCAB
BioAtla Inc.
as 11-22-2024 4:00pm EST
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 101.0M | IPO Year: | 2020 |
| Target Price: | $5.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.14 - $4.02 | Next Earning Date: | 11-07-2024 |
| Revenue: | $11,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BioAtla Inc. News
BCAB Breaking Stock News: Dive into BCAB Ticker-Specific Updates for Smart Investing
MT Newswires
11 days ago
HC Wainwright Downgrades BioAtla to Neutral From Buy
GuruFocus.com
16 days ago
BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Simply Wall St.
17 days ago
3 Promising US Penny Stocks With At Least $90M Market Cap
GlobeNewswire
17 days ago
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
24 days ago
BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024
Simply Wall St.
25 days ago
BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake
Insider Monkey
a month ago
BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025
GuruFocus.com
a month ago
BioAtla Inc (BCAB) Q2 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges
Compare BCAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCAB BioAtla Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.